157 related articles for article (PubMed ID: 31348916)
21. Liquid chromatography electrospray-mass spectrometry of urinary aflatoxin biomarkers: characterization and application to dosimetry and chemoprevention in rats.
Walton M; Egner P; Scholl PF; Walker J; Kensler TW; Groopman JD
Chem Res Toxicol; 2001 Jul; 14(7):919-26. PubMed ID: 11453740
[TBL] [Abstract][Full Text] [Related]
22. Identification of a Fused-Ring 2'-Deoxyadenosine Adduct Formed in Human Cells Incubated with 1-Chloro-3-buten-2-one, a Potential Reactive Metabolite of 1,3-Butadiene.
Zeng FM; Liu LY; Zheng J; Kong C; An J; Yu YX; Zhang XY; Elfarra AA
Chem Res Toxicol; 2016 Jun; 29(6):1041-50. PubMed ID: 27161607
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of trihydroxybutyl mercapturic acid, a urinary metabolite of 1,3-butadiene, in humans.
Kotapati S; Matter BA; Grant AL; Tretyakova NY
Chem Res Toxicol; 2011 Sep; 24(9):1516-26. PubMed ID: 21749114
[TBL] [Abstract][Full Text] [Related]
24. Accurate quantification of the mercapturic acids of acrylonitrile and its genotoxic metabolite cyanoethylene-epoxide in human urine by isotope-dilution LC-ESI/MS/MS.
Schettgen T; Bertram J; Kraus T
Talanta; 2012 Aug; 98():211-9. PubMed ID: 22939149
[TBL] [Abstract][Full Text] [Related]
25. Urinary biomarkers of 1,3-butadiene in environmental settings using liquid chromatography isotope dilution tandem mass spectrometry.
Sapkota A; Halden RU; Dominici F; Groopman JD; Buckley TJ
Chem Biol Interact; 2006 Mar; 160(1):70-9. PubMed ID: 16423335
[TBL] [Abstract][Full Text] [Related]
26. Validation of putative biomarkers of furan exposure through quantitative analysis of furan metabolites in urine of F344 rats exposed to stable isotope labeled furan.
Kalisch C; Reiter M; Krieger M; Wüst L; Klotz C; Dekant R; Lachenmeier DW; Scherf-Clavel O; Mally A
Arch Toxicol; 2024 Jun; 98(6):1741-1756. PubMed ID: 38573339
[TBL] [Abstract][Full Text] [Related]
27. Species differences in urinary butadiene metabolites: comparisons of metabolite ratios between mice, rats, and humans.
Bechtold WE; Strunk MR; Chang IY; Ward JB; Henderson RF
Toxicol Appl Pharmacol; 1994 Jul; 127(1):44-9. PubMed ID: 8048052
[TBL] [Abstract][Full Text] [Related]
28. Analysis of butadiene urinary metabolites by liquid chromatography-triple quadrupole mass spectrometry.
McDonald JD; Bechtold WE; Krone JR; Blackwell WB; Kracko DA; Henderson RF
J Anal Toxicol; 2004 Apr; 28(3):168-73. PubMed ID: 15107146
[TBL] [Abstract][Full Text] [Related]
29. Species differences in urinary butadiene metabolites; identification of 1,2-dihydroxy-4-(N-acetylcysteinyl)butane, a novel metabolite of butadiene.
Sabourin PJ; Burka LT; Bechtold WE; Dahl AR; Hoover MD; Chang IY; Henderson RF
Carcinogenesis; 1992 Sep; 13(9):1633-8. PubMed ID: 1394848
[TBL] [Abstract][Full Text] [Related]
30. A method for the quantification of biomarkers of exposure to acrylonitrile and 1,3-butadiene in human urine by column-switching liquid chromatography-tandem mass spectrometry.
Schettgen T; Musiol A; Alt A; Ochsmann E; Kraus T
Anal Bioanal Chem; 2009 Feb; 393(3):969-81. PubMed ID: 19018522
[TBL] [Abstract][Full Text] [Related]
31. Identification of novel metabolites of butadiene monoepoxide in rats and mice.
Richardson KA; Peters MM; Megens RH; van Elburg PA; Golding BT; Boogaard PJ; Watson WP; van Sittert NJ
Chem Res Toxicol; 1998 Dec; 11(12):1543-55. PubMed ID: 9860500
[TBL] [Abstract][Full Text] [Related]
32. A column-switching LC-MS/MS method for simultaneous quantification of biomarkers for 1,3-butadiene exposure and oxidative damage in human urine.
Zhang X; Hou H; Chen H; Liu Y; Wang A; Hu Q
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():123-9. PubMed ID: 26319305
[TBL] [Abstract][Full Text] [Related]
33. Detection of carboxylic acids and inhibition of hippuric acid formation in rats treated with 3-butene-1,2-diol, a major metabolite of 1,3-butadiene.
Sprague CL; Elfarra AA
Drug Metab Dispos; 2003 Aug; 31(8):986-92. PubMed ID: 12867486
[TBL] [Abstract][Full Text] [Related]
34. Determination of the major mercapturic acids of 1,3-butadiene in human and rat urine using liquid chromatography with tandem mass spectrometry.
Urban M; Gilch G; Schepers G; van Miert E; Scherer G
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 796(1):131-40. PubMed ID: 14552824
[TBL] [Abstract][Full Text] [Related]
35. Hemoglobin adducts and micronuclei in rodents after treatment with isoprene monoxide or butadiene monoxide.
Fred C; Grawé J; Törnqvist M
Mutat Res; 2005 Aug; 585(1-2):21-32. PubMed ID: 15925539
[TBL] [Abstract][Full Text] [Related]
36. High-throughput quantitation of amino acids in rat and mouse biological matrices using stable isotope labeling and UPLC-MS/MS analysis.
Takach E; O'Shea T; Liu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Aug; 964():180-90. PubMed ID: 24842860
[TBL] [Abstract][Full Text] [Related]
37. Biomarkers of exposure to 1,3-butadiene as a basis for cancer risk assessment.
van Sittert NJ; Megens HJ; Watson WP; Boogaard PJ
Toxicol Sci; 2000 Jul; 56(1):189-202. PubMed ID: 10869468
[TBL] [Abstract][Full Text] [Related]
38. Measuring urinary N-acetyl-S-(4-hydroxy-2-methyl-2-buten-1-yl)-L-cysteine (IPMA3) as a potential biomarker of isoprene exposure.
Alwis KU; Bailey TL; Patel D; Wang L; Blount BC
Anal Chim Acta; 2016 Oct; 941():61-66. PubMed ID: 27692379
[TBL] [Abstract][Full Text] [Related]
39. Biotransformation of 2,3,3,3-tetrafluoropropene (HFO-1234yf).
Schuster P; Bertermann R; Snow TA; Han X; Rusch GM; Jepson GW; Dekant W
Toxicol Appl Pharmacol; 2008 Dec; 233(2):323-32. PubMed ID: 18817801
[TBL] [Abstract][Full Text] [Related]
40. Studies on the metabolic activation of disulfiram in rat. Evidence for electrophilic S-oxygenated metabolites as inhibitors of aldehyde dehydrogenase and precursors of urinary N-acetylcysteine conjugates.
Hu P; Jin L; Baillie TA
J Pharmacol Exp Ther; 1997 May; 281(2):611-7. PubMed ID: 9152363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
